Alnylam Pharmaceuticals
ALNY
#457
Rank
C$70.83 B
Marketcap
C$536.16
Share price
-5.56%
Change (1 day)
49.10%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company